# Title

 Food and Drugs. PART 315â€”DIAGNOSTIC RADIOPHARMACEUTICALS


# ID

 CFR-2018-title21-vol5.Pt. 315


# Structured Analysis Summary

| Type        | Values                                   |
|:------------|:-----------------------------------------|
| Constraints | ['within', 'maximum', 'more than']       |
| Condition   | ['when', 'where']                        |
| Entities    | ['Food', 'Indications', 'Scope', 'Such'] |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                              |
|:--------------|:---------------------------------------------------------------------------------------------------------------------|
| more than     | biochemical, physiological, anatomical, or pathological process or to more than  one disease or condition.           |
| within        | (5) For a claim that does not fall  within the indication categories identified in &#167;&#8201;315.4, the applicant |
| maximum       | The  maximum  tolerated dose need not be established.                                                                |


## Condition

| Condition   | Context                                                                                               |
|:------------|:------------------------------------------------------------------------------------------------------|
| where       | In situations  where a particular radiopharmaceutical is proposed for both diagnostic                 |
| where       | or to more than one disease or condition. where                                                       |
| when        | with the carrier or ligand of the radiopharmaceutical when the same chemical entity as the carrier or |


## Entities

| Entities    | Context                                              |
|:------------|:-----------------------------------------------------|
| Food        | Food  and Drugs.                                     |
| Scope       | Scope .                                              |
| Indications | Indications .                                        |
| Such        | Such information may include, but is not limited to, |


